1Neugut AI,Ahsan H,Robinson E. Pancreas cancer as a second primary malignancy[J]. Cancer, 1995,76(4) :589-592.
2Robinson E, Neugut AI. Clinical aspects of multiple primary neoplasms[J]. Cancer Detect Prey, 1989,13 ( 5-6 ) :287-292.
3Berg JW, Schottenfeld D. Incidence of multiple primary cancer. II. Cancers of the respiratory and upper digestive system as multiple primary cancers[J]. J Natl Cancer Inst, 1970,44 :264-274.
4Moiler H, Mellemgaard A, Jacobsen GK, et al. Incidence of second primary cancer following testicular cancer[J]. Eur J Cancer,1993,29A(5) :672-676.
5McCredie M, Macfarlane GJ, Bell J, et al. Second primary cancers after cancers of the colon and rectum in New South Australia, 1972-1991 [J]. Cancer Epidemiol Bioraarkers Prey,1997,6(3):155-160.
6Hong WK, Lippman SM, Itri LM,et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck[J]. New Engl J Med, 1990, 323 (12):795-801.
7Pastorino U ,Sozzi G, Miozzo M ,et al. Genetic changes in lung cancer[J]. J Cell Biochem, 1993,17 (Suppl) : 237-248.
8Ritts RE,Pitt HA. CA19-9 in pancreatic cancer[J]. Surg Oncol Clin N Am,!998,7(1):93-101.
9Nouts A, Levy P, Voitot H, et al. Diagnostic value of serum CA19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma[J ]. Gastroenterol Clin Biol, 1998,22 (2) : 152-159.
10Paterson MC, Dietrich KD, Danyluk J, et al. Correlation between c-erB-2 amplificative breast cancer[J]. Cancer Res,1991,51(2):556.
